【レポートの概要（一部）】
1. Executive Summary
1.1 Top Stem Cell Technology Companies: Overview of Findings
1.2 Report Contents
1.3 Study Methods – Research and Analysis
1.4 Scope and Format of Report
2. Leading US Stem Cell Technology Companies, 2014
2.1 Aastrom Biosciences
2.1.1 Stem Cell Technology Platform
2.1.2 Aastrom: Stem Cell Pipeline, 2014
2.1.2.1 Ixmyelocel-T: Patient-Specific Therapy Reduces Risk of Rejection
2.1.2.2 Orphan Designation to Accelerate Product Development
2.1.3 Sales and Recent Performance, 2012
2.1.4 Aastrom: Stem Cell SWOT Analysis, 2014-2024
2.1.5 Aastrom: Stem Cell Revenue Forecast, 2014-2024
2.2 Advanced Cell Technology (ACT)
2.2.1 Stem Cell Technology Platform
2.2.2 ACT: Stem Cell R&D Pipeline, 2014
2.2.2.1 Human Embryonic Stem Cells: Aiding Tissue Repair
2.2.3 Sales and Recent Performance, 2012
2.2.4 ACT: Stem Cell SWOT Analysis, 2014-2024
2.2.5 ACT: Stem Cell Revenue Forecast, 2014-2024
2.3 Bioheart
2.3.1 Bioheart: Stem Cell Pipeline, 2014
2.3.2 Sales and Recent Performance, 2012
2.3.3 Bioheart: Stem Cell SWOT Analysis, 2014-2024
2.3.4 Bioheart: Stem Cell Revenue Forecast, 2014-2024
2.3.4.1 Increased Activity Abroad Will Help Bioheart Attract Investment
2.4 BrainStorm Cell Therapeutics
2.4.1 Brainstorm Cell Therapeutics: Stem Cell Pipeline, 2014
2.4.2 Brainstorm Cell Therapeutics: Stem Cell SWOT Analysis, 2014-2024
2.4.3 Brainstorm Cell Therapeutics: Stem Cell Revenue Forecast, 2014-2024
2.4.3.1 Government Grant Will Provide Much Needed Investment
2.5 California Stem Cell Inc.
2.5.1 California Stem Cell: Stem Cell Pipeline, 2014
2.5.2 California Stem Cell: Stem Cells SWOT Analysis, 2014-2024
2.6 International Stem Cell Corporation (ISCO)
2.6.1 ISCO: Stem Cell Pipeline, 2014
2.6.2 Sales and Recent Performance, 2012
2.6.3 ISCO: Stem Cells SWOT Analysis, 2014-2024
2.6.4 Cosmetic Subsidiary Expands Into Asian Market
2.7 NeoStem
2.7.1 NeoStem: Stem Cell Pipeline, 2014
2.7.1.1 AMR-001: Highly Efficacious Therapy for AMI
2.7.1.2 T-Cell Therapy: Using Autologous Immune Cells as Therapy
2.7.1.3 VSEL Technology: Promoting Cell Migration to Site of Damage
2.7.2 Sales and Recent Performance, 2012
2.7.3 NeoStem: Stem Cell SWOT Analysis, 2014-2024
2.7.4 NeoStem: Stem Cell Revenue Forecast, 2014-2024
2.8 Neuralstem
2.8.1 Stem Cell Technology Platform
2.8.2 Neuralstem: Stem Cell Pipeline, 2014
2.8.2.1 NSI-566: Potential Therapy in Multiple Neurological Disorders
2.8.2.2 NSI-189: Deriving Cells from the Hippocampal Region
2.8.3 Sales and Recent Performance, 2012
2.8.4 Neuralstem: Stem Cell SWOT Analysis, 2014-2024
2.8.5 Neuralstem: Stem Cell Revenue Forecast, 2014-2024
2.9 Medistem
2.9.1 Medistem: Stem Cell Pipeline, 2014
2.9.2 Medistem: Stem Cell SWOT Analysis, 2014-2024
2.9.3 Medistem: Stem Cell Revenue Forecast, 2014-2024
2.9.3.1 Expansion of Clinical Indications Through Acquisition
2.10 Osiris Therapeutics
2.10.1 Osiris Therapeutics: Stem Cell Products
2.10.2 Osiris Therapeutics: Stem Cell Pipeline, 2014
2.10.3 Sales and Recent Performance, 2012
2.10.4 Osiris Therapeutics: Stem Cell SWOT Analysis, 2014-2024
2.10.5 Osiris Therapeutics: Stem Cell Revenue Forecast, 2014-2024
2.11 Other US Companies Operating in the Stem Cells Technology Industry, 2014
3. Top European and Israeli Stem Cell Technology Companies, 2014
3.1 Apceth
3.1.1 Apceth: Stem Cell Pipeline, 2014
3.1.1.1 Alecmestencel-T: Options for Autologous and Allogeneic Therapy
3.1.1.2 Agenmestencel-T: Genetically-modified Therapy for Cancer
3.1.2 Apceth: Stem Cell SWOT Analysis, 2014-2024
3.1.3 Apceth: Stem Cell Revenue Forecast, 2014-2024
3.2 Cardio3 BioSciences
3.2.1 Cardio3 BioSciences: Stem Cell Pipeline, 2014
3.2.1.1 C-Cure®: Creating New Muscle Cells
3.2.2 Cardio3 BioSciences: Stem Cell SWOT Analysis, 2014-2024
3.2.3 Cardio3 BioSciences: Stem Cell Revenue Forecast, 2014-2024
3.3 Cell Cure Neurosciences
3.3.1 Cell Cure Neurosciences: Stem Cell Pipeline, 2014
3.3.2 Cell Cure Neurosciences: Stem Cell SWOT Analysis, 2014-2024
3.4 TiGenix
3.4.1 Stem Cell Technology Platform
3.4.2 TiGenix: Stem Cell Products
3.4.2.1 ChondroCelect: One of Few Marketed Stem Cell Products
3.4.3 TiGenix: Stem Cell Pipeline, 2014
3.4.3.1 Cx601: Promoting Natural Close of Fissure
3.4.3.2 Cx611: Landmark Results of a Cell Therapy in Rheumatoid Arthritis
3.4.3.3 Cx621: Novel, Painless Route of Administration?
3.4.4 Sales and Recent Performance, 2012
3.4.5 TiGenix: Stem Cell SWOT Analysis, 2014-2024
3.4.6 TiGenix: Stem Cell Revenue Forecast, 2014-2024
3.5 Gamida Cell
3.5.1 Stem Cell Technology Platform
3.5.1.1 Copper Chelator-based Technology
3.5.1.2 Nicotinamide (NAM) Platform
3.5.2 Gamida Cell: Stem Cell Pipeline, 2014
3.5.2.1 StemEx: Huge Market Potential in Patient Numbers
3.5.2.2 NiCord: Transplanting Two Units of Umbilical Cord Blood
3.5.3 Gamida Cell: Stem Cell SWOT Analysis, 2014-2024
3.5.4 Gamida Cell: Stem Cell Revenue Forecast, 2014-2024
3.6 Pluristem Therapeutics
3.6.1 Stem Cell Technology Platform:
3.6.2 Pluristem Therapeutics: Stem Cell Pipeline, 2014
3.6.2.1 PLX-PAD: Clinical Hold Notification May Delay Approval
3.6.2.2 PLX-RAD: Accelerating Cell Engraftment in Bone Marrow Transplantation
3.6.3 US and Korea Licence Partnerships to Drive Revenue
3.6.4 Sales and Recent Performance, 2013
3.6.5 Pluristem Therapeutics: Stem Cell SWOT Analysis, 2014-2024
3.6.6 Pluristem Therapeutics: Stem Cell Revenue Forecast, 2014-2024
3.7 ReNeuron
3.7.1 ReNeuron: Stem Cell Technology Platform
3.7.2 ReNeuron: Stem Cell Pipeline, 2014
3.7.2.1 ReN001: Groundbreaking Therapy in Development
3.7.2.2 ReN009: Avoiding Possible Limb Amputation
3.7.2.3 ReN003: Grant and Partnership with Leading US University Will Drive Development
3.7.3 Sales and Recent Performance, 2013
3.7.4 ReNeuron: Stem Cell SWOT Analysis, 2014-2024
3.7.5 ReNeuron: Stem Cell Revenue Forecast, 2014-2024
3.8 Other European and Israeli Companies Operating in the Stem Cells Technology Industry, 2014
4. Top Asia-Pacific Stem Cell Technology Companies, 2014
4.1 Anterogen
4.1.1 Anterogen: Stem Cell Products
4.1.1.1 Cupistem®: World’s First MSC Product From Adipose Tissue
4.1.1.2 Queencell®:
4.1.2 Anterogen: Stem Cell Pipeline, 2014
4.1.3 Anterogen: Stem Cell SWOT Analysis, 2014-2024
4.2 MEDIPOST
4.2.1 Stem Cell Technology Platform
4.2.2 MEDIPOST: Stem Cell Pipeline, 2014
4.2.2.1 Cartistem: A Top 25 Science Technology
4.2.2.2 Neurostem: Restorative Therapy for Neurological Disease
4.2.2.3 Pneumostem: Treatment for Paediatric Population
4.2.2.4 Promostem: Encouraging Engraftment of Cells Following Transplantation
4.2.3 Sales and Recent Performance, 2014
4.2.4 MEDIPOST: Stem Cell SWOT Analysis, 2014-2024
4.2.5 MEDIPOST: Stem Cell Revenue Forecast, 2014-2024
4.2.5.1 Collaboration with an Indian Company Expands Reach in Asia
4.3 Mesoblast
4.3.1 Stem Cell Technology Platform
4.3.2 Mesoblast: Stem Cell Pipeline, 2014
4.3.2.1 Immunology and Inflammatory Diseases
4.3.2.2 Spinal Disease
4.3.2.3 Cardiac and Vascular Disease
4.3.2.4 Oncology
4.3.2.5 Other Indications
4.3.3 Sales and Recent Performance, 2012
4.3.4 Mesoblast: Stem Cell SWOT Analysis, 2014-2024
4.3.5 Mesoblast: Stem Cell Revenue Forecast, 2014-2024
4.4 Pharmicell
4.4.1 Pharmicell: Stem Cell Products
4.4.1.1 Hearticellgram-AMI: World First Cell Therapy for Acute Myocardial Infarction
4.4.2 Pharmicell: Stem Cell Pipeline, 2014
4.4.3 Sales and Recent Performance, 2012
4.4.4 Pharmicell: Stem Cell SWOT Analysis, 2014-2024
4.4.5 Pharmicell: Stem Cell Revenue Forecast, 2014-2024
4.5 Stempeutics Research
4.5.1 Stem Cell Technology Platform
4.5.2 Stempeutics Research: Stem Cell Pipeline, 2014
4.5.2.1 Stempeucel®: Launch in Fast-Growing Asian Markets
4.5.2.2 Stempeucare™: Cosmetic Growth Factor Treatment
4.5.3 Stempeutics Research: Stem Cell SWOT Analysis, 2014-2024
4.5.4 Stempeutics Research: Stem Cell Revenue Forecast, 2014-2024
4.5.4.1 Cipla Alliance to Drive Revenue as Wider Population Targeted
5. The World Stem Cell Technology Market, 2014-2024
5.1 The World Stem Cell Technology Market, 2012
5.2 The World Stem Cell Technology Market: Revenue Forecast to 2024
5.2.1 What Will Drive The World Stem Cell Technology Market Between 2014 and 2024?
5.2.2 What Factors are Likely to Restrain the World Stem Cell Technology Market Between 2014 and 2024?
5.3 The Stem Cell Technology Market: Revenue Forecast by Therapeutic Application, 2014-2024
5.3.1 How Will Market Shares of Leading Stem Cell Therapeutic Applications Change from 2014-2024?
6. Stem Cell Technologies: Industry Trends, 2014-2024
6.1 Strengths and Weaknesses of The Stem Cell Technologies Market
6.2 Strengths
6.2.1 Stem Cells Are Finally Proving Their Worth
6.3 Weaknesses
6.3.1 Many Difficulties Still to Overcome
6.4 Opportunities and Threats in the Stem Cell Technologies Market
6.4.1 Stem Cells Have Unprecedented Clinical Potential
6.4.2 Regulatory and Commercial Instability Threatens the Field
6.5 STEP Analysis of the Stem Cell Technologies Market, 2014-2024
6.5.1 Social Concerns: A Controversial Technology
6.5.2 Technological Developments: Stem Cell Science Still on the March
6.5.3 Economic Factors: Funding Gaps a Concern
6.5.4 Political Issues: State Attitudes Vital to Research Environment
7. Opinions from Research Interviews
7.1 Dr Robin Smith: Chairman and CEO, NeoStem
7.1.1 The Potential of Stem Cell Therapy
7.1.2 Competition in the Stem Cell Arena
7.1.3 NeoStem’s Products and Technology
7.1.4 Concerns over Stem Cell Therapy
7.1.5 Future Directions for NeoStem and Stem Cell Therapy
7.2 Dr Yael Margolin, President and CEO, Gamida Cell
7.2.1 Stem Cell Therapy and Their Therapeutic Promise
7.2.2 Gamida Cell’s NiCord Product and Umbilical Cord Blood
7.2.3 Partnership with a Leading Pharmaceutical Company
7.2.4 Barriers to Stem Cell Therapy Uptake
8. Conclusions
8.1 The US Leads the Field for Stem Cell Research
8.2 Market Remains Under-Capitalised, in Need of Financing
8.3 Many Barriers Still to Overcome for Companies
8.4 New Entrants to the Market Will Increase Competition
【レポート販売概要】
■ タイトル：主要な幹細胞（ステムセル）技術企業分析（2014-2024）■ 英文：Pharma Leader Series: Top Stem Cell Technology Companies 2014-2024
■ 発行日：2014年3月
■ 調査会社：visiongain
■ 商品コード：Visiongain-4052643
■ 調査対象地域：グローバル
- FISHプローブの世界市場2016-2020FISH probe is a molecular diagnostic technique that utilizes labeled DNA probes to either detect or confirm gene or abnormalities in the chromosome. Technavio’s analysts forecast the global fish probe market to grow at a CAGR of 7.34% during the period 2016-2020. [Covered in this report] The report covers the present scenario and the growth prospects of the global fish probe market for 2016-2020. …
- 保護コーティングの世界市場2016-2020：溶剤型コーティング、水性コーティング、粉体コーティングAbout Protective Coatings Protective coatings are generally layered as protective systems, where layers are systematically applied. These systems may be a single coat or can be a combination of multiple layers of same or different generic types. This together forms a coating system consisting of one or more coats, applied in a predetermined order by prescribed methods, and generally involves surfa …
- 消費者ヘルスケアの世界市場：市販薬、ダイエットサプリメントAbout Consumer Healthcare The characteristics of consumer health products vary widely, with the two most important elements being the consumer needs they address and the strength of the claims made. The market for consumer-focused healthcare products is increasingly occupying the space between consumer needs and growing prevalence of lifestyle diseases. As consumer health companies develop a combi …
- 発酵槽の世界市場予測（～2023年）“The fermenters market is projected to grow at a CAGR of 8.4%.”The fermenters market is estimated at USD 1.13 billion in 2018 and is projected to grow at a CAGR of 8.4%, to reach USD 1.69 billion by 2023. The market is driven by factors such as increased consumption of fermented beverages in developed economies, change in consumer perception of fermentation with regard to health claims, and growth …
- 気密包装の世界市場分析：製品別（金属からセラミック、ガラスから金属、トランスポンダガラス、リードガラス、パッシベーションガラス）、用途別（航空、防衛、自動車、医療、テレコム）、セグメント予測、2014-2025The global hermetic packaging market is expected to reach USD 5.03 billion by 2025, according to a new report by Grand View Research, Inc. Utilization of hermetic packages is expected to grow significantly as a result of increasing application scope from healthcare and aeronautics & space application.The capability of the product to protect electronic components from temperature, pressure, and liq …
- 自動車ディスプレイ装置の世界市場2017-2021About automotive display systemAdvances in technology and the increased use of smart devices in the automotive segment have increased the adoption of automotive human-machine interface (HMI) solutions. An input component is a device through which a user provides information and the device that provides information or performs a required activity is called an output component. Display systems form …
- 米国の末梢血管処置用機器市場見通し（～2021）United States Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "United States Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the United States Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection P …
- 定量ポンプの世界市場予測（～2021）：ダイアフラムポンプ、ピストンポンプ、プランジャポンプThe metering pumps market is projected to reach USD 5.22 Billion by 2021, at a CAGR of 6.2% from 2016 to 2021. Metering pumps used in several end-use industries such as, water treatment, chemical processing, pharmaceuticals, food & beverages, pulp & paper, petrochemicals, and oil & gas industries. The increasing usage of metering pumps across these industries is expected to drive the market for th …
- ガスエンジンの世界市場2015-2019About gas engine A gas engine is essentially an internal combustion engine that generates motive power by using a variety of natural gasses as fuel. The basic components of a gas engine generator includes a heat exchanger, an engine, control panels, and a generator. Natural gas, used as fuel in gas engines, is a versatile, clean-burning, and efficient fuel that is used in a wide variety of applica …
- 幹細胞バンクの世界市場：臍帯血バンク、コード組織バンクThe global stem cell banking market is expected to reach USD 3.96 Billion by 2021 from USD 1.58 Billion in 2016, at a CAGR of 20.2% from 2016 to 2021. Increasing awareness regarding the storage of cord blood and tissue stem cells, high growth potential of emerging economies, and increasing use of stem cells in the field of therapeutics have opened an array of opportunities for the growth of the ma …
- 世界の映像（Video）管理ソフトウェア市場（2014-2018）TechNavio's analysts forecast the Global Video Management Software market to grow at a CAGR of 18.51 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing security concerns. The Global Video Management Software market has also been witnessing the increasing demand for high-quality images. However, the lack of standardization could pose a cha …
- Bounty Oil & Gas NL：石油・ガスバリューチェーン分析レポート2013Bounty Oil & Gas NL Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Bounty Oil & Gas NL" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Bounty Oil & Gas NL”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- 慢性骨髄性白血病：企業と競争環境PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing CML Market. The report identifies and analyses the key companies shaping and drivi …
- 自動車用パワーステアリングギヤの世界市場About Automotive Power Steering GearsAutomotive power steering helps the driver to steer the wheels by controlling the steering effort on the wheel. In power steering, electric motors help the steering motion instead of hydraulic systems. Technavio’s analysts forecast the global automotive power steering gears market to grow at a CAGR of 3.94% during the period 2017-2021. [Covered in this report] …
- アテレクトミー（粥腫切除術）デバイスの世界市場予測（～2022年）The atherectomy devices market projected to grow at a CAGR of 6.1%The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising dem …
